
Serox Ltd is an Oxford-based company developing a groundbreaking, low-cost, non-invasive diagnostic tool that uses urine samples to identify cancer at the point of need. The company harnesses photonics, bio quantum-sensing, and AI, utilizing Surface Enhanced Raman Spectroscopy (SERS) to analyze and classify complex biological fluids. Their disease-agnostic approach allows for optimized diagnostics for various cancers, enabling multi-test cartridges and personalized diagnostic models. Serox aims to transform global healthcare by delivering innovative solutions for early detection, better patient outcomes, and a healthier world, with a focus on reducing the time and cost of clinical diagnosis by avoiding costly and invasive procedures like biopsies.

Serox Ltd is an Oxford-based company developing a groundbreaking, low-cost, non-invasive diagnostic tool that uses urine samples to identify cancer at the point of need. The company harnesses photonics, bio quantum-sensing, and AI, utilizing Surface Enhanced Raman Spectroscopy (SERS) to analyze and classify complex biological fluids. Their disease-agnostic approach allows for optimized diagnostics for various cancers, enabling multi-test cartridges and personalized diagnostic models. Serox aims to transform global healthcare by delivering innovative solutions for early detection, better patient outcomes, and a healthier world, with a focus on reducing the time and cost of clinical diagnosis by avoiding costly and invasive procedures like biopsies.